Type 2 Diabetes Mellitus and Vertebral Fracture Risk

Research output: Contribution to journalArticleAcademicpeer-review

23 Citations (Scopus)
11 Downloads (Pure)


Purpose of Review: The purpose of this review is to summarize the recently published evidence concerning vertebral fracture risk in individuals with diabetes mellitus. Recent Findings: Vertebral fracture risk is increased in individuals with T2DM. The presence of vertebral fractures in T2DM is associated with increased non-vertebral fracture risk and mortality. TBS could be helpful to estimate vertebral fracture risk in individuals with T2DM. An increased amount of bone marrow fat has been implicated in bone fragility in T2DM. Results from two recent studies show that both teriparatide and denosumab are effective in reducing vertebral fracture risk also in individuals with T2DM. Summary: Individuals with T2DM could benefit from systematic screening in the clinic for presence of vertebral fractures.

Original languageEnglish
Pages (from-to)50-57
Number of pages8
JournalCurrent Osteoporosis Reports
Issue number1
Publication statusPublished - 12 Jan 2021

Bibliographical note

Funding Information:
S.G. is funded by the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 860898. L.O. is funded by an Erasmus MC fellowship grant.

Publisher Copyright:
© 2021, The Author(s).

Research programs

  • EMC OR-01


Dive into the research topics of 'Type 2 Diabetes Mellitus and Vertebral Fracture Risk'. Together they form a unique fingerprint.

Cite this